Media Highlights and Announcements

John Barrington discusses the company’s move into the US market, and its use of artificial intelligence in diagnosing early indicators for heart disease in clinical settings.

Learn More

Artrya Ltd announced the appointment of US Cardiologist Nicolas Chronos, MD, to its Clinical Advisory Board. He will promote key medical research partnerships and oversee US based research in support of Artrya’s US market entry.

Learn More

Artrya’s CMO, Professor Girish Dwivedi, writes how CT scanning of the heart has changed how coronary artery disease can be assessed.

Learn More

Artrya has opened a new US operation in Los Angeles. The company will market its AI-based solution, Artrya Salix, a device capable of analysing cardiac CT scans to illustrate a combination of coronary artery disease biomarkers.

Learn More

Australian medical technology company, today announces the formation of the Company’s American subsidiary, Artrya USA, Inc. (Artrya US)

Learn More

Ted Schwab and Jory Tremblay have been appointed as co-CEOs of the company’s US subsidiary.

Learn More

The Medical RepublicMarch 01, 2022

Heart disease: the case for early detection

Dr Brendan Adler opinion piece on the need for an affordable and accessible option for treating patients with early coronary artery disease.

Learn More

John Barrington AM talks to ausbiz about the company’s strategy across the US, UK and Europe, and shares insights into the recent December quarter update.

Learn More

John Barrington AM talks to Proactive Investor about the company’s appointment of Dr. Jacque Sokolov as Chair of Artrya’s Clinical Advisory Board.

Learn More

Artrya Limited (ASX: AYA, Artrya or the Company) is today announcing the appointment of renowned healthcare executive Dr. Jacque J. Sokolov as Chair of Artrya’s Clinical Advisory Board.

Learn More